Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Validation of Hemolytic Anemia Codes in the French Hospital Database

Julien Maquet, Hélène Derumeaux, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 3460.

https://doi.org/10.1182/blood-2019-124697

Published: 2019

Journal Articles

Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in Myeloproliferative Neoplasms (MPN) - Data from the Bioregistry of the German Study Group for MPN (GSG-MPN)

Blood (2018) 132 (Supplement 1): 4292.

https://doi.org/10.1182/blood-2018-99-112377

Published: 2018

Journal Articles

A Study to Identify Correlation of Hematopoietic Progenitor Cell(XN-HPC) By Sysmex Cell Counters with Final Yield of CD34 + Stem Cells

Kishore Kumar, MBBS, MD DM, Chezhian s Subash, FRCPath

Blood (2017) 130 (Supplement 1): 5458.

https://doi.org/10.1182/blood.V130.Suppl_1.5458.5458

Published: 2017

Journal Articles

Measurement of Liver Iron Concentration in a Population of Non-Transfusion Dependent Thalassemia Patients Using a Trained Artificial Neural Network to Analyse Magnetic Resonance Images

Tim St Pierre, PhD, Tony Cooper, Nguyen Ngoc Trang, Nguyen Thi Thu Ha, Dang Thai Ton, Nguyen Khoi Viet, Pham Minh Thong, Nguyen Anh Tri, Bach Quoc Khanh, Sherif Boulos, Michael House, Wenjie Pang, Sander Bangma, Ali Taher, MDPhDFRCP

Blood (2017) 130 (Supplement 1): 2212.

https://doi.org/10.1182/blood.V130.Suppl_1.2212.2212

Published: 2017

Journal Articles

Discovery of Predictive Gene Signatures for Tumor Sensitivity to MDM2 Inhibition in Development of a Novel MDM2 Inhibitor DS-3032b

Jo Ishizawa, MD PhD, Kenji Nakamaru, Takahiko Seki, Koichi Tazaki, Kensuke Kojima, MD PhD, Dhruv Chachad, Courtney D DiNardo, MD, Sherry Pierce, BSN, BA, Keyur P. Patel, MD PhD, Archie Tse, R Eric Davis, MD, Arvind Rao, PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 2893.

https://doi.org/10.1182/blood.V128.22.2893.2893

Published: 2016

Journal Articles

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

Luca Malcovati, MD, Anna Gallì, Erica Travaglino, Ilaria Ambaglio, MD, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, MD, Silvia Catricalà, Elisa Bono, MD, Antonio Bianchessi, MD, Gabriele Todisco, MD, Elisa Rumi, MD, Virginia Valeria Ferretti, Elli Papaemmanuil, PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 298.

https://doi.org/10.1182/blood.V128.22.298.298

Published: 2016

Journal Articles

Serum Free Light Chain Responses Have Greater Concordance with Clinical Outcomes Than Those Assessed By Urine Electrophoresis in Light Chain Multiple Myeloma Patients

Thomas Dejoie, PharmD, Michel Attal, Philippe Moreau, Herve Avet-Loiseau, MD PhD

Blood (2016) 128 (22): 376.

https://doi.org/10.1182/blood.V128.22.376.376

Published: 2016

Journal Articles

External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans

Neela K Kumar, MSPH, Erin R Weeda, PharmD, Philip S Wells, MD, Frank Peacock, MD, Gregory J Fermann, MD, Li Wang, MA, PhD MBA, Onur Baser, MS, PhD, Jeff Schein, DrPH, MPH, Crivera Crivera, PharmD, MPH, Craig I Coleman, PharmD, Christine G Kohn, PharmD

Blood (2016) 128 (22): 533.

https://doi.org/10.1182/blood.V128.22.533.533

Published: 2016

Journal Articles

Validation of an Algorithm Identifying Incident Primary Immune Thrombocytopenia in the French National Health Insurance Database

Salim Mezaache, Hélène Derumeaux, MD PhD, Pierre Ferraro, MD, Pascal Capdebon, MD, Jean-Christophe Steinbach, MD, Xavier Aballe, MD, Deborah Palas, MD, Nabil Saichi, MD, Franck Burgan, MD, Karine Desboeuf, MD, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Guillaume Moulis, MD PhD

Blood (2016) 128 (22): 4764.

https://doi.org/10.1182/blood.V128.22.4764.4764

Published: 2016

Journal Articles

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

Richard T. Silver, Ariella Barel, Elena Lascu, BA,MA, Ellen K. Ritchie, MD, Gail J. Roboz, MD, Paul Christos, Attilio Orazi, MD, Duane C Hassane, PhD, Wayne Tam, MD PhD, Nicholas C.P. Cross, PhD

Blood (2016) 128 (22): 944.

https://doi.org/10.1182/blood.V128.22.944.944

Published: 2016

Journal Articles

A Phase 1/2 Study of NS-018, an Oral JAK2 Inhibitor, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (pPV MF), or Post-Essential Thrombocythemia Myelofibrosis (pET MF)

Srdan Verstovsek, MD, Moshe Talpaz, MD, Ellen Ritchie, MD, Martha Wadleigh, MD, Olatoyosi Odenike, MD, Catriona Jamieson, MD PhD, Brady Stein, MD, Tomonori Uno, PhD, Ruben A. Mesa

Blood (2015) 126 (23): 2800.

https://doi.org/10.1182/blood.V126.23.2800.2800

Published: 2015

Journal Articles

Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism

Wendy Hsiao, BS, Thomas Delate, PhD MS, Daniel M Witt, PharmD, Melissa R Meyer, PharmD, Alan Go, MD, Margaret Fang, MD MPH, Benjamin Kim, MD MPhil

Blood (2014) 124 (21): 3513.

https://doi.org/10.1182/blood.V124.21.3513.3513

Published: 2014

Journal Articles

Association of Hematological Nadirs and Survival in a Non-Human Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome

Zoya Gluzman Poltorak, PhD MBA, Vainstein Vladimir, MD MS, Lena A. Basile, PhD JD

Blood (2014) 124 (21): 4354.

https://doi.org/10.1182/blood.V124.21.4354.4354

Published: 2014

Journal Articles

Stop Light: Mortality Risk In Adult Sickle Cell Disease and Criteria For Hematopoietic Stem Cell Transplant

Seth Rotz, MD, Mary Ann O'Riordan, PhD, Ceonne Kim, Marcos de Lima, MD, Mark T. Gladwin, MD, Jane A. Little, MD

Blood (2013) 122 (21): 2227.

https://doi.org/10.1182/blood.V122.21.2227.2227

Published: 2013

Journal Articles

Retrospective Analysis Of 204 Patients With Polycythemia VERA: The International Working Group For Myeloproliferative Neoplasm Research and Treatment (IWG-MRT) Prognostic Score Is A Good Predictor Of Survival and Prognosis

Giulia Benevolo, MD, Elena Crisà, MD, Barbara Nicolino, MD, Patrizia Pregno, MD, Eloise Beggiato, MD, Andrea Evangelista, Dario Ferrero, MD, Laura Godio, Mario Boccadoro, MD, Umberto Vitolo, MD

Blood (2013) 122 (21): 4072.

https://doi.org/10.1182/blood.V122.21.4072.4072

Published: 2013

Journal Articles

Hepcidin Levels Predict Non-Responsiveness to Oral Iron Therapy in Patients with Iron Deficiency Anemia

Lawrence T. Goodnough, David Morris, Todd Koch, Andy He, David Bregman

Blood (2012) 120 (21): 484.

https://doi.org/10.1182/blood.V120.21.484.484

Published: 2012

Journal Articles

Reproducibility of International Harmonization Project (IHP)-Based Interpretations of Posttherapy PET/CT in Patients with Hodgkin's and Aggressive Non-Hodgkin's Lymphoma.

Malik E. Juweid, MD, Damita Thomas, MD, Kevin Berbaum, David Bushnell, Michael M Graham

Blood (2009) 114 (22): 1556.

https://doi.org/10.1182/blood.V114.22.1556.1556

Published: 2009

NARROW

Validation of Hemolytic Anemia Codes in the French Hospital Database

Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in Myeloproliferative Neoplasms (MPN) - Data from the Bioregistry of the German Study Group for MPN (GSG-MPN)

A Study to Identify Correlation of Hematopoietic Progenitor Cell(XN-HPC) By Sysmex Cell Counters with Final Yield of CD34 + Stem Cells

Measurement of Liver Iron Concentration in a Population of Non-Transfusion Dependent Thalassemia Patients Using a Trained Artificial Neural Network to Analyse Magnetic Resonance Images

Discovery of Predictive Gene Signatures for Tumor Sensitivity to MDM2 Inhibition in Development of a Novel MDM2 Inhibitor DS-3032b

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

Serum Free Light Chain Responses Have Greater Concordance with Clinical Outcomes Than Those Assessed By Urine Electrophoresis in Light Chain Multiple Myeloma Patients

External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans

Validation of an Algorithm Identifying Incident Primary Immune Thrombocytopenia in the French National Health Insurance Database

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

A Phase 1/2 Study of NS-018, an Oral JAK2 Inhibitor, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (pPV MF), or Post-Essential Thrombocythemia Myelofibrosis (pET MF)

Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism

Association of Hematological Nadirs and Survival in a Non-Human Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome

Stop Light: Mortality Risk In Adult Sickle Cell Disease and Criteria For Hematopoietic Stem Cell Transplant

Retrospective Analysis Of 204 Patients With Polycythemia VERA: The International Working Group For Myeloproliferative Neoplasm Research and Treatment (IWG-MRT) Prognostic Score Is A Good Predictor Of Survival and Prognosis

Hepcidin Levels Predict Non-Responsiveness to Oral Iron Therapy in Patients with Iron Deficiency Anemia

Reproducibility of International Harmonization Project (IHP)-Based Interpretations of Posttherapy PET/CT in Patients with Hodgkin's and Aggressive Non-Hodgkin's Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only